Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yimei Que"'
Autor:
Xiaolu Long, Ning An, Chunhui Li, Hui Zhu, Haojie Li, Qiuxia Yu, Yimei Que, Menglei Xu, Zhe Li, Wei Chen, Shuai Wang, Di Wang, Chunrui Li
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
The outcome of AL amyloidosis remains poor, particularly in patients with advanced organ involvement which takes long time to recovery. We conducted an observational study of two patients with AL amyloidosis treated with SDd regimen. Both patients su
Externí odkaz:
https://doaj.org/article/a3e188e780cc45aa8108badce038c569
Autor:
Di Wang, Haiying Fu, Yimei Que, Haitao Ruan, Menglei Xu, Xiaolu Long, Qiuxia Yu, Chunhui Li, Zhe Li, Songbai Cai, Wei Chen, Cong Sun, Guang Hu, Shuai Wang, Donggou He, Jianming Mei, Wen Wang, Chunrui Li
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background Extramedullary disease usually implies a dismal outcome in relapsed/refractory multiple myeloma patients, and requires novel treatment approaches. We designed a trial using Selinexor, a nuclear export protein 1 inhibitor, together
Externí odkaz:
https://doaj.org/article/f3a34539f48349448a5f00e1e8c45a6c
Autor:
Di Wang, Li He, Chunhui Li, Menglei Xu, Qiuxia Yu, Varlene Daniela Fernandes Almeida, Yimei Que, Yanjie Xu, Yi Xiao, Chunrui Li
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background Chimeric antigen receptor T-cell therapy (CAR-T) has yielded unprecedented efficacy in B-cell malignancies. With the increasing use of CAR-T-cell therapy, infection has become one of the major concerns after CAR-T-cell infusion. S
Externí odkaz:
https://doaj.org/article/d29bb24738084cb299bafd5c1da1059a
Autor:
Yanjie Xu, Xia Mao, Yimei Que, Menglei Xu, Chunhui Li, Varlene Daniela Fernandes Almeida, Di Wang, Chunrui Li
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background B cell maturation antigen (BCMA) targeted immunotherapies have demonstrated remarkable clinical efficacy in multiple myeloma (MM). Here, we evaluated the BCMA expression in MM and other plasma cell dyscrasias (PCDs), hoping to pro
Externí odkaz:
https://doaj.org/article/50c92142c9104605a2ed151c71255c2e
Autor:
Di Wang, Xia Mao, Yimei Que, Menglei Xu, Yuhang Cheng, Liang Huang, Jue Wang, Yi Xiao, Wen Wang, Guang Hu, Shangkun Zhang, Tongcun Zhang, Chunrui Li, Jianfeng Zhou
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/6aae130ad05442eab3dabb9af81ab475
Autor:
Ying Wang, Jianfeng Zhou, Wei Zhang, Wen Wang, Dan li, Xia Mao, Liang Huang, Chunrui Li, Min Xiao, Yimei Que, Shengnan Ding, Guang Hu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
B cell maturation antigen (BCMA)-directed CAR-T cell therapy is a disruptive approach for treating relapsed/refractory multiple myeloma (R/R MM); however, optimization is necessary to maximize patient benefit. We report the case of a 61-year-old woma
Externí odkaz:
https://doaj.org/article/50616918607a4282b6bdc1cda226ad60
Publikováno v:
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-14 (2020)
Abstract Background Outcomes of chronic myeloid leukemia (CML) has been improved dramatically in the past two decades, but survival levels of CML patients varied in regions. Comprehensive epidemiological research is necessary to evaluate the global b
Externí odkaz:
https://doaj.org/article/b933c18a919e4b3ea7d75463d2fedb5f
Autor:
Yimei Que, Menglei Xu, Yanjie Xu, Varlene Daniela Fernandes Almeida, Li Zhu, Zhiqiong Wang, Ying Wang, Xian Liu, Lijun Jiang, Di Wang, Chunrui Li, Jianfeng Zhou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe prognosis of relapsed/refractory multiple myeloma (RRMM) patients with the extramedullary disease was significantly poor. Extramedullary multiple myeloma (EMM) patients gained limited benefits from traditional drugs. Anti-B cell maturat
Externí odkaz:
https://doaj.org/article/fcfc53f970b2413694a1af7b8104e952
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
DNA (cytosine-5)-methyltransferase 3A (DNMT3A)-mutated acute myeloid leukemia (AML) has a poor prognosis, but the exact mechanism is still unclear. Here, we aimed to explore the mechanism of immune escape in AML with DNMT3A mutation. We constructed a
Externí odkaz:
https://doaj.org/article/6659b176c5ab450783d1cd7e8f7f9f9f
Autor:
Chunrui Li, Wenyue Cao, Yimei Que, Qiuxiang Wang, Yi Xiao, Chaojiang Gu, Di Wang, Jue Wang, Lijun Jiang, Hao Xu, Jinhuan Xu, Xiaoxi Zhou, Zhenya Hong, Na Wang, Liang Huang, Shangkun Zhang, Liting Chen, Xia Mao, Min Xiao, Wei Zhang, Li Meng, Yang Cao, Tongcun Zhang, Jian Li, Jianfeng Zhou
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 3, Pp n/a-n/a (2021)
Abstract Background Relapsed/refractory (R/R) multiple myeloma (MM) patients and primary plasma cell leukemia (PCL) have an unfavorable prognosis and no effective treatment. This study was designed to assess the safety and preliminary efficacy of a n
Externí odkaz:
https://doaj.org/article/07029acdfadf4fcf91408ac9363b959a